.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Colorcon
Fuji
Federal Trade Commission
Moodys
McKesson
UBS
AstraZeneca
Queensland Health
Covington

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202085

« Back to Dashboard

NDA 202085 describes DESOGESTREL AND ETHINYL ESTRADIOL, which is a drug marketed by Duramed Pharms Barr, Accord Hlthcare, Aurobindo Pharma Ltd, Mayne Pharma, Mylan Labs Ltd, Novast Labs Ltd, and Watson Labs, and is included in nine NDAs. It is available from eight suppliers. Additional details are available on the DESOGESTREL AND ETHINYL ESTRADIOL profile page.

The generic ingredient in DESOGESTREL AND ETHINYL ESTRADIOL is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.

Summary for 202085

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 202085

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DESOGESTREL AND ETHINYL ESTRADIOL desogestrel; ethinyl estradiol TABLET;ORAL-28 202085 ANDA Mylan Pharmaceuticals Inc. 0378-7282 0378-7282-53 3 POUCH in 1 CARTON (0378-7282-53) > 1 BLISTER PACK in 1 POUCH (0378-7282-85) > 1 KIT in 1 BLISTER PACK
DESOGESTREL AND ETHINYL ESTRADIOL desogestrel; ethinyl estradiol TABLET;ORAL-28 202085 ANDA Afaxys Pharma, LLC 50102-154 50102-154-03 3 POUCH in 1 CARTON (50102-154-03) > 1 BLISTER PACK in 1 POUCH (50102-154-01) > 1 KIT in 1 BLISTER PACK (50102-154-00)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.15MG;0.03MG
Approval Date:May 20, 2015TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Express Scripts
UBS
US Department of Justice
Medtronic
McKinsey
Novartis
Farmers Insurance
US Army
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot